How big is the frontotemporal dementia market | Size, Share & Forecast 2026

Q: How big is the frontotemporal dementia market size?

The frontotemporal dementia market is projected to reach USD 3.3 Billion by 2031.

Q: What is the CAGR of the frontotemporal dementia market during the forecast period?

The frontotemporal dementia market is expected to grow at a CAGR of 6.30% during the forecast period.

Q: Who is most commonly affected by frontotemporal dementia market?

FTD primarily affects individuals between 45 and 65 years of age, unlike Alzheimer which targets older adults.

Q: What treatment approaches are under development for FTD?

Gene therapies, monoclonal antibodies, and anti-inflammatory agents are key approaches under clinical investigation.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA7137

Publication Date: Jul 2025

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full global frontotemporal dementia market.

View Main Report Schedule Analyst Call

How big is the frontotemporal dementia market?

According to 6Wresearch internal database and industry insights, the global frontotemporal dementia market was valued at USD 2.1 Billion in 2025 and is expected to reach USD 3.3 Billion by 2032, growing at a compound annual growth rate of 6.30% during the forecast period (2026-2032).

The frontotemporal dementia (FTD) market is growing steadily due to increasing worldwide awareness, advances in neuroscience, and rising demand for early diagnosis and treatment options. FTD primarily affects individuals under 65 years of age, making it one of the leading causes of early-onset dementia.

Key Growth Factors of the Frontotemporal Dementia Market

Increasing prevalence of early-onset dementia and aging-related disorders
Rising demand for neuroimaging and molecular diagnostic tools
Accelerated R&D for disease-modifying treatments and rare disease focus
Advancements in genomic studies and identification of FTD-linked mutations
Growing healthcare expenditure and neurodegenerative disease awareness
Expansion of memory clinics and specialized neurological care centers

Frontotemporal Dementia Market Trends

The frontotemporal dementia market is experiencing rising adoption of precision medicine and personalized treatment approaches. Non-invasive brain imaging techniques like MRI and PET scans are enhancing early diagnosis. Genetic testing and biomarker-based detection are becoming standard in clinical evaluations. In addition, digital health tools and cognitive tracking software are supporting remote monitoring and care delivery, especially for patients in early stages of the disease.

Emerging Developments in the Frontotemporal Dementia Market

Emerging developments in the frontotemporal dementia market include AI-assisted diagnostic tools, wearable neurological sensors, and cloud-based brain health platforms. Pharmaceutical companies are advancing monoclonal antibody therapies, RNA-based treatments, and neuroprotective compounds. Digital cognitive therapy applications and caregiver support solutions are also emerging as integral parts of the FTD care ecosystem.